You are here
IVF Trials Boost for BlueGnome
Results of a new study show that technology from BlueGnome in Cambridge can offer “dramatic benefit to IVF success,” the UK company has revealed.
BlueGnome unveiled the results of the first randomised prospective IVF study of pre-implantation chromosome analysis using its 24sure array platform.
The study, published in The Journal of Molecular Cytogenetics by Yang et al (Pacific Reproductive Center,Torrance, USA) has demonstrated that selectively implanting euploid embryos, with a normal number of chromosomes, significantly increases pregnancy rates.